# OrbusNeich Medical to invest 300M yuan in largest R&D and production base in Hangzhou

OrbusNeich Medical (06929) plans to invest 300 million yuan in a vascular interventional medical device R&D and production base in Hangzhou, China. The facility will be the company's largest and have an annual capacity of about 2.4 million units.

- Type: Investment
- Announced: 2023-03-28
- Where: Hangzhou, Zhejiang, China
- Value: $44.0M (300.0M CNY)
- Status: announced
- Capacity: 2.4 million units per year
- Products: vascular interventional medical devices
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [OrbusNeich Medical](https://endata.com/companies/69366.md)

## Sources

- [beta.zhitongcaijing.com](http://beta.zhitongcaijing.com/content/detail/901063.html), 2023-03-29: "新基地将成为旗下最大的研发及生产设施。"

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.